The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
Our updated brochure on Who we are, What we do, and How we work – with an overview of the project portfolio 2014-2017
Read about TB vaccine investments, epidemic preparedness projects, the fellowship programme and the planned 2018 calls for proposals.
EDCTP holds ‘trainer-of-trainers’ workshop on GCP-GCLP in Johannesburg, South Africa
The EDCTP Africa Office organised a workshop on Good Clinical Practice/Good Clinical Laboratory Practice in Johannesburg, South Africa, from 12-14 June 2018. Participants of 26 EDCTP-funded projects – including from the four EDCTP-funded regional Networks of Excellence – from 15…
European Commission presents next research & innovation framework ‘Horizon Europe’
The European Commission (EC)published its proposal for Horizon Europe, a €100 billion research and innovation programme, on 7 June 2018. The proposal is part of the next European Union long-term budget. Horizon Europe 2021 – 2027 will succeed Horizon 2020…